We are live on !
Find out more
AlphaCentric Advisors Portfolio holdings
AUM
$113M
Turnover
27.4%
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+27.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$5.41M
(-4.6%)
Cap. Flow
+$2.01M
Cap. Flow % of AUM
Cap. Flow %
1.79%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
292
New
33
Increased
148
Reduced
40
Closed
47
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.34M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$1.59M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$1.58M |
| 4 |
Alpine Income Property Trust
PINE
|
+$1.46M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apogee Therapeutics
APGE
|
+$1.53M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.37M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.37M |
| 4 |
Howard Hughes
HHH
|
+$1.07M |
| 5 |
SmartStop Self Storage REIT
SMA
|
+$812K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.1% |
| 2 | Miscellaneous | 19.55% |
| 3 | Technology | 9.14% |
| 4 | Industrials | 8.04% |
| 5 | Real Estate | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Scholar Rock
SRRK
$5.27B
| $472K | 0.42% |
+9,760
| New | +$514K |
2026 Q3
0 quarters
|
|
77
Disc Medicine
IRON
$3.64B
| $469K | 0.42% |
7,161
+3,131
| +78% | +$237K |
2025 Q4
3 quarters
|
|
78
Serve Robotics
SERV
$229M
| $465K | 0.41% |
100,000
| – | – |
2025 Q4
3 quarters
|
|
79
Xeris Biopharma Holdings
XERS
$3.04B
| $464K | 0.41% |
48,489
+1,940
| +4% | +$16.4K |
2025 Q4
3 quarters
|
|
80
AH Realty Trust
AHRT
$471M
| $458K | 0.41% |
75,000
-40,000
| -35% | -$268K |
2025 Q4
3 quarters
|
|
81
Loews
L
$22.6B
| $454K | 0.4% |
4,346
+332
| +8% | +$37.2K |
2023 Q4
11 quarters
|
|
82
iShares JPMorgan EM High Yield Bond ETF
EMHY
$545M
| $435K | 0.39% |
11,223
-1,008
| -8% | -$40.4K |
2023 Q1
14 quarters
|
|
83
Celldex Therapeutics
CLDX
$2.26B
| $431K | 0.38% |
13,299
+515
| +4% | +$19.7K |
2026 Q1
2 quarters
|
|
84
Micron Technology
MU
$881B
| $427K | 0.38% |
401
+29
| +8% | +$27.5K |
2026 Q1
2 quarters
|
|
85
Kratos Defense & Security Solutions
KTOS
$6.38B
| $427K | 0.38% |
10,000
| – | – |
2025 Q4
3 quarters
|
|
86
Immunovant
IMVT
$7.07B
| $415K | 0.37% |
+12,276
| New | +$484K |
2026 Q3
0 quarters
|
|
87
D-Wave Quantum Inc
QBTS
$3.63B
| $414K | 0.37% |
25,000
| – | – |
2026 Q2
1 quarter
|
|
88
Johnson & Johnson
JNJ
$688B
| $410K | 0.36% |
1,549
+158
| +11% | +$41.7K |
2026 Q1
2 quarters
|
|
89
Candel Therapeutics
CADL
$474M
| $399K | 0.35% |
38,259
+1,576
| +4% | +$17.5K |
2026 Q1
2 quarters
|
|
90
Chubb
CB
$144B
| $399K | 0.35% |
+1,227
| New | +$424K |
2026 Q3
0 quarters
|
|
91
Rigetti Computing
RGTI
$3.3B
| $394K | 0.35% |
25,000
| – | – |
2026 Q2
1 quarter
|
|
92
Cytokinetics
CYTK
$7.82B
| $391K | 0.35% |
5,933
+236
| +4% | +$18K |
2025 Q4
3 quarters
|
|
93
Bank of New York Mellon
BNY
$103B
| $383K | 0.34% |
2,650
+268
| +11% | +$42.1K |
2024 Q1
10 quarters
|
|
94
NewAmsterdam Pharma
NAMS
$2.42B
| $378K | 0.34% |
15,549
+681
| +5% | +$18.8K |
2025 Q4
3 quarters
|
|
95
HCA Healthcare
HCA
$104B
| $378K | 0.34% |
886
+85
| +11% | +$34.8K |
2024 Q1
10 quarters
|
|
96
Definium Therapeutics
DFTX
$4.39B
| $366K | 0.33% |
+9,616
| New | +$405K |
2026 Q3
0 quarters
|
|
97
Trevi Therapeutics
TRVI
$1.95B
| $363K | 0.32% |
25,370
+1,053
| +4% | +$18.1K |
2025 Q4
3 quarters
|
|
98
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.73B
| $362K | 0.32% |
8,772
+989
| +13% | +$41.6K |
2023 Q1
14 quarters
|
|
99
Ventas
VTR
$47B
| $358K | 0.32% |
4,212
+433
| +11% | +$39.7K |
2026 Q1
2 quarters
|
|
100
Intuitive Machines
LUNR
$2.1B
| $356K | 0.32% |
25,000
| – | – |
2024 Q3
8 quarters
|
|
Similar funds
TWS
AlphaCentric Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, AlphaCentric Advisors held 292 positions worth $113M, down 4.6% from $118M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AlphaCentric Advisors's Q3 2026 filing shows 33 new, 148 increased, 40 reduced and 47 closed positions. Its largest new stake was Alpine Income Property Trust: 75,000 shares worth $1.3M. The largest sale was Apogee Therapeutics, an estimated $1.53M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 44% a quarter earlier, followed by Miscellaneous and Technology.
- AlphaCentric Advisors's largest Q3 2026 buy was Alpine Income Property Trust: 75,000 shares worth $1.3M.
- AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q3 2026, an estimated $4.34M increase.
- AlphaCentric Advisors's biggest Q3 2026 reduction was Graphic Packaging, cutting an estimated $428K.
- AlphaCentric Advisors fully exited Apogee Therapeutics in Q3 2026, selling an estimated $1.53M.
- AlphaCentric Advisors's ten largest holdings make up 23% of its $113M portfolio in Q3 2026.
- AlphaCentric Advisors opened 33 new positions and closed 47 in Q3 2026.
- AlphaCentric Advisors's portfolio value fell 4.6% quarter-over-quarter to $113M.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.